Literature UpdateBasic Science

Induced Pluripotent Stem Cells (iPSCs): Molecular Mechanisms of Induction and Applications

Signal Transduction and Targeted Therapy · 2024

Last updated: Nov 16, 2026

Cerneckis et al. review how mature cells can be reprogrammed into induced pluripotent stem cells (iPSCs) and differentiated into specialized cell types. They describe how patient-derived cells, organoids, and other models are used to study disease mechanisms, screen drugs, and develop cell therapies.

For musculoskeletal research, these approaches offer a way to study tissue development and disease using human cells. Models and potential therapies have different validation needs. For cell replacement, the review discusses challenges such as cell maturity, product heterogeneity, and safety.

Clinical relevance: An iPSC-derived model can be useful for studying disease or evaluating a candidate treatment well before a cell product is ready for clinical testing.

OrthoRico Take-home Message: iPSCs expand the ways researchers can model human disease. Cell replacement additionally requires evidence that the transplanted cells are safe, functional, and durable.